Genomics

Dataset Information

Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes


ABSTRACT: Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes

PROVIDER: PRJNA1129529 | ENA |

REPOSITORIES: ENA